NEW YORK, Nov. 2, 2026 /PRNewswire/ -- One of the fastest-growing healthcare suppliers, HSS Medical Supply, announced a new vendor agreement with Abbott. The family-owned distribution company now includes Abbott's ID NOW™, a rapid molecular testing platform, in its catalog of over 2,000 products, expanding its point-of-care offerings.

Abbott's ID NOW Platform

Abbott is a global leader in rapid point-of-care diagnostics. Its ID NOW™ platform is an instrument-based molecular testing system used to detect common infectious diseases. Delivering results in minutes, this compact, CLIA-waived benchtop instrument is designed for clinics, physician offices, urgent care centers, and outpatient clinics with a Certificate of Waiver. It runs single-patient tests and delivers lab-grade results for Flu A & B, RSV, and COVID-19 in 13 minutes or less, with Strep A results in under 6 minutes.

Bringing Lab-Grade Accuracy to the Point of Care

Standard rapid antigen tests detect surface viral or bacterial proteins, often with lower specificity. ID NOW instead target-amplifies the organism's genetic material. This molecular approach reduces false negatives, improving flu diagnostic accuracy to above 96% and antigen detection accuracy from 81% to 87%.

Molecular testing eliminates the need for confirmatory culture tests following a negative Strep A result, reducing administrative workload for clinics and healthcare providers.

Receiving results while the patient is still in the examination room allows practitioners to initiate targeted treatment plans during a single visit. Abbott's ID NOW platform also helps prevent unnecessary antimicrobial prescriptions by providing rapid molecular results.

The process improves patient convenience and clinic throughput while eliminating patient callbacks and minimizing follow-up visits.

Molecular diagnostic codes (CPT codes) carry higher reimbursement rates from major insurance payers compared to traditional rapid antigen testing codes. This can increase operational revenue while elevating the standard of care.

"Our goal has always been to equip healthcare providers with the highest-grade tools to deliver exceptional patient care. Adding Abbott's ID NOW platform to our product portfolio allows us to offer practitioners a reliable, highly accurate diagnostic solution," said Peter McCann, Co-Founder of HSS Medical Supply. "Cutting diagnostic time and accelerating treatments means more and more people get care early, before the condition worsens."

About HSS Medical Supply

HSS Medical Supply is a family-owned and operated medical distribution company, founded by Peter McCann and Patrick Kiss. The company officially launched operations on November 1, 2025, and provides competitive pricing on medical supplies, equipment, and pharmaceuticals. Its experienced sales representatives bring decades of industry expertise. The company's mission is to make advanced medical and pharmaceutical supplies accessible to large hospitals and small clinics.

With an inventory of over 20,000 products, HSS Medical Supply delivers to healthcare facilities throughout New York, Massachusetts, North Carolina, and New Jersey. Inventory managers can visit the website to browse the catalog and apply for an account. For queries, contact HSS Medical Supply at +1 (833) 477-1001 or info@hssmedicalsupply.com.

Media Contact
Peter McCann
833-477-1001
426012@email4pr.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/hss-medical-supply-announces-distributor-agreement-for-abbotts-id-now-rapid-molecular-testing-platform-302924892.html

SOURCE HSS Medical Supply